EBGLYSS is set to transform the treatment experience for patients living with moderate-to-severe atopic dermatitis after the US Food and Drug Administration (FDA) approved a new extended maintenance dosing schedule.
Concord Biotech shares surged in trade on June 10 after the company received a major regulatory boost from the United States Food and Drug Administration (USFDA). The rally came after Concord Biotech secured approval for its Abbreviated New Drug...
Phox Health Revolutionizes Medicine Delivery in India as the US-based healthcare logistics company officially launches its India operations, marking a significant step in the country's evolving healthcare supply chain sector.
India may be preparing to offer fresh support to the pharmaceutical industry as it considers extending customs duty exemptions on key petrochemical imports. The proposed duty relief for pharma raw materials comes at a time when drug manufacturers...
India is strengthening global pharmaceutical partnerships to drive innovation, expand manufacturing, and accelerate healthcare growth, with the USD 60 billion industry aiming to double in size over five years.
India gets its first AI-Powered mammography system from FUJIFILM as the healthcare technology company announced the installation of its advanced AMULET SOPHINITY digital mammography platform at NM Medical, one of India's leading...
India’s MedTech opportunity is emerging as a major growth driver for the country’s electronics manufacturing services (EMS) industry. As competition intensifies in consumer electronics manufacturing and margins remain under pressure, leading EMS...
Bayer has launched Alka-Seltzer in India’s OTC digestive health segment, introducing an antacid with probiotic support to address acidity, gas and indigestion.
India’s anti-obesity drug market is slowing after a semaglutide-led boom, as generic sales growth moderated following the initial surge triggered by lower-cost alternatives.
India is preparing a major policy initiative aimed at boosting domestic pharmaceutical innovation, with the government working on a new scheme focused on the bulk drug research ecosystem. The proposed initiative is expected to strengthen...